iPremom

€15M SeedRaised yesterdayValencia, SpainHealthcare & MedtechSpain
Visit website →

Why now

Where iPremom is today

iPremom announced a funding round of €15M on 4 September 2026, led by Amadeus Capital Partners.

Latest round
Seed
Amount
€15M
Announced
4 September 2026
Headquarters
Valencia, Spain
Sector
Healthcare & Medtech
Investors
Amadeus Capital Partners
Also participating
Asabys Partners and APEX Ventures
Relevant leadership
Chief Executive Officer Alfonso Sánchez along with co-founder and Chairman Professor Carlos Sim

Momentum AfterRaise intelligence

AfterRaise Score

62
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
10/20
Seed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

In their own words

What iPremom says it is doing

Work here? Add to this

Public signal Described in the funding announcement as "diagnostics femtech startup". Source

Market expansionResearch and developmentCommercial growthRegulatoryEuropean expansion

Public signal Read from the company's own description of what the funding supports.

Since the raise

What has happened since

  • 4 September 2026
    €15M Seed
    Led by Amadeus Capital Partners.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What happens next

What this raise plausibly creates

AfterRaise inferenceAfterRaise intelligence

Likely next Moves

  • European market entry
  • New market entry
  • First local hires in the new market
  • Local entity and legal setup

Opportunities this could create

  • Regulatory affairs
  • Quality systems
  • Clinical hiring
  • Provider partnerships
  • Market-entry advisers

Based on the Healthcare & Medtech sector, a Seed round and the priorities the company itself set out. Not a statement of fact.

High momentum6 connected signals
  • 4 September 2026€15M Seed announced
  • 4 September 2026Stated priority: market expansion
  • 4 September 2026Stated priority: research and development
  • 4 September 2026Stated priority: commercial growth
  • 4 September 2026Stated priority: regulatory
  • 4 September 2026Stated intent: european expansion AfterRaise intelligence

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What iPremom is open to

Not yet specified

iPremom has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with iPremom

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its page and published them.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

Your company is growing. Tell people what you need next.

This page belongs to iPremom. Claim it to say where you are going, correct anything AfterRaise got wrong, publish the work you have open, and choose who may approach you. Companies are more protected after claiming, not less: you decide what kinds of approach you want, and we refuse the rest.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Also moving

Other Healthcare & Medtech companies

See the sector